Bangalore: Syngene International Limited has announced that Jonathan Hunt has stepped down from his role as MD & CEO as well as from the Board of Directors to pursue other opportunities in ...

Bengaluru, popularly known as Bangalore, is a hi-tech city that is also known as the ‘Silicon Valley of India’ due to wide spread presence of IT industry. Bangalore offers high career opportunities ...

Vijay Kumar K S, a 39-year-old software professional, made a remarkable Rs 11 crore from Rs 50 lakh invested in stocks over 10 years, only to lose it within a month through “digital arrest”, the ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

By offering Qartemi at a significantly accessible price compared to global alternatives, we are proud to develop this therapy indigenously at our facility in Bangalore to ensure global standards of ...

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.

A Spanish tourist has reportedly alleged that he was asked to speak in Kannada by an emergency helpline operator when he made a call during a burglary at his home. Jesus Abrielle, who visited ...

On April 4, 1949, Parveen Babi was born, marking the beginning of a journey for one of India's most celebrated actresses during the 1970s and 1980s. Despite facing a society and media that were often ...

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...